Veidlapa Nr. M-3 (8)
Study Course Description

Integrated Pharmacy

Main Study Course Information

Course Code
FFK_014
Branch of Science
Basic medicine
ECTS
3.00
Target Audience
Pharmacy
LQF
Level 7
Study Type And Form
Full-Time; Part-Time

Study Course Implementer

Course Supervisor
Structure Unit Manager
Structural Unit
Department of Pharmacology and Pharmacotherapy
Contacts

Riga, 21 Consula Street, farmkk@rsu.lv, +371 67061544

About Study Course

Objective

• To promote the acquisition of knowledge about the main groups of drugs, their chemical structure and properties, the profile of the associated effect and side effects. • To promote skills of analysis and interpretation of the purpose of therapeutic action of medicinal substances. • To promote understanding of the influence of chemical structure on the mechanism of drug substance interaction, the importance of proper use.

Preliminary Knowledge

Pharmaceutical chemistry, qualitative and quantitative analysis, organic and inorganic chemistry, pharmacology, physics, mathematics.

Learning Outcomes

Knowledge

1.On successful acquisition of the course the students will be able to: • will be able to evaluate the therapeutic activity of medicinal substances depending on the chemical structure, physico-chemical properties of the substance; • will be able to compare medicinal substances within one therapeutic group; • will be able to demonstrate knowledge of the predicted mechanism and incidence of adverse drug reactions; • will be able to assess the effect of non-medicinal factors on the therapeutic effect.

Skills

1.On successful acquisition of the course the students will be able to: • to compile and systematize the current information regarding the medicinal products reviewed in the study course, their characteristics, properties, use in medicine; • to create presentations and research projects on medicinal substances, compiling the most up-to-date information from the SPCs and clinical trials published in recent years.

Competences

1.On successful completion of the study course, as a result of successful acquisition of the study course, students will be able to evaluate medicinal substances within one therapeutic group of medicinal products depending on the possibility of side effects and pharmacological effect; will be able to develop theoretical and practical analysis projects, interpret the obtained data in accordance with the specifics of the research topic.

Assessment

Individual work

Title
% from total grade
Grade
1.

Individual work

-
-
Individual presentations and scientific project according to the course topic using literature data. It is recommended to fill in the study course survey, evaluating the existing course content and creating proposals for updating the course.

Examination

Title
% from total grade
Grade
1.

Examination

-
-
Presentation according to the course topic (50%). Final written exam (50%).

Study Course Theme Plan

FULL-TIME
Part 1
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Integrated pharmacy, its relationship with chemistry, the role in the model of the health care system.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Presentation of therapeutic data depending on the target audience.
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Interpretation and analysis of phenotypic, pharmacokinetic, laboratory data from pilot studies. Development of research protocols.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Interpretation and analysis of phenotypic, pharmacokinetic, laboratory data from pilot studies. Development of research protocols.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Informed patient consent. Development of research protocols.
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Consequences of medication misuse (eg candidiasis) and solutions.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Interpretation and analysis of laboratory data.
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Therapeutic drug monitoring benefits and prerequisites for proper performance.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Irrational use of the drug depending on the dosage form.
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Anticoagulants and antiplatelet agents - factors that affect the monitoring of therapeutic drugs, dosage, frequency of use.
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Elements of consultation on the proper use of medicines. Disposal of the medicinal product after expiry date.
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Active substances and excipients - areas of influence in the production process, in the operation of medicines
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Active substances and excipients - areas of influence in the production process, in the operation of medicines
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Overview of drug interactions - benefits and risks.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Pilot project presentations on individually selected topics
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Pilot project presentations on individually selected topics
Total ECTS (Creditpoints):
3.00
Contact hours:
32 Academic Hours
Final Examination:
Exam (Written)
PART-TIME
Part 1
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Interpretation and analysis of phenotypic, pharmacokinetic, laboratory data from pilot studies. Development of research protocols.
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Interpretation and analysis of laboratory data.
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Elements of consultation on the proper use of medicines. Disposal of the medicinal product after expiry date.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Overview of drug interactions - benefits and risks.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Informed patient consent. Development of research protocols.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Overview of drug interactions - benefits and risks.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Pilot project presentations on individually selected topics
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Irrational use of the drug depending on the dosage form.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Pilot project presentations on individually selected topics
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Active substances and excipients - areas of influence in the production process, in the operation of medicines
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Active substances and excipients - areas of influence in the production process, in the operation of medicines
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Active substances and excipients - areas of influence in the production process, in the operation of medicines
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Presentation of therapeutic data depending on the target audience.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Interpretation and analysis of phenotypic, pharmacokinetic, laboratory data from pilot studies. Development of research protocols.
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Pilot project presentations on individually selected topics
Total ECTS (Creditpoints):
3.00
Contact hours:
30 Academic Hours
Final Examination:
Exam (Written)

Bibliography

Required Reading

1.

Clinical Pharmacy and Therapeutics. / edited by Cate Whittlesea and Karen Hodson. 6th edition. Oxford: Elsevier, 2019. xiv, 1094 lpp.

2.

Maisto, Stephen A. Drug use and abuse / Stephen A. Maisto, Gerard J. Connors. 8th edition. Boston, MA : Cengage, 2019, xiv, 514 lpp. (brošēts).

3.

Oxford handbook of clinical pharmacy. / edited by Philip Wiffen, Marc Mitchell, Melanie Snelling, Nicola Stoner. 3rd edition. New York: Oxford University Press, 2017. xvi, 728 lpp.

Additional Reading

1.

Drug Delivery Systems / edited by Rakesh K. Tekade. London : Academic Press an imprint of Elsevier, [2019], 2020. xiii, 777 lpp. Advances in pharmaceutical product development and research. (iesiets).

2.

Integrated pharmacy case studies. / edited by Sally-Anne Francis, Felicity Smith, et.al. London: Pharmaceutical Press, 2015. xx, 432 lpp.

Other Information Sources

1.

Drugs

2.

Uptodate